
|Videos|February 2, 2022
Tech Talks: Cell & Gene Therapy Series
Author(s)PPD
Cell and gene therapies continue to expand rapidly, with an anticipated exponential growth over the next five years. This rapid growth has left an urgent need for industry scientists to gather and share lessons learned concerning bioanalytical, biomarker and regulatory strategies. This series provides insight from PPD Laboratories’ experts into a variety of cell and gene therapy (CGT) modalities in the bioanalytical community, with detailed discussions that leverage their experience with technologies and modalities within this CGT sphere.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
3
PharmTech’s Top 10 Articles of 2025
4
How GLP-1s, Digital Tech, and 505(b)(2) Strategies Are Reshaping the CDMO Landscape
5




